title: Acquired epidermodysplasia verruciformis: a comprehensive review and a proposal for treatment.
abstract: BACKGROUND
  Epidermodysplasia verruciformis (EV) is a rare genodermatosis characterized by immunologic abnormalities, disseminated human papilloma virus infection, and early development of skin cancers. Acquired forms have been rarely reported and usually occur with immunosuppression. The therapeutic management of the acquired forms is not standardized, and several therapies have been tried, with variable outcomes.
  
  
  OBJECTIVE
  To provide updated clinical and experimental information on the treatment of acquired EV.
  
  
  METHODS
  A Medline literature search was performed for relevant Medical Subject Heading terms, reviewing publications on strategies for management of acquired EV. We also report a case successfully treated using a combination of photodynamic therapy and oral retinoids.
  
  
  CONCLUSIONS
  Data from the literature show that a standardized approach to this condition is lacking; the combination treatment chosen in our case may be proposed because it led to an excellent clinical outcome and a long-lasting remission.
authors: Department of Dermatology, Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy. anna.zampetti@rm.unicatt.it
authors: Anna
authors: A
authors: Zampetti
authors: Federica
authors: F
authors: Giurdanella
authors: Simona
authors: S
authors: Manco
authors: Dennis
authors: D
authors: Linder
authors: Maria
authors: M
authors: Gnarra
authors: Giuseppe
authors: G
authors: Guerriero
authors: Claudio
authors: C
authors: Feliciani
mesh_terms: D000284:Administration, Oral; D000622:Aminolevulinic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D003131:Combined Modality Therapy; D003972:Diathermy; D004819:Epidermodysplasia Verruciformis / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008875:Middle Aged; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000008:administration & dosage*; D012176:Retinoids / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D017319:Photosensitizing Agents; D012176:Retinoids; C475457:methyl 5-aminolevulinate; D000622:Aminolevulinic Acid